Literature DB >> 9176673

1996 Jules Gonin Lecture of the Retina Research Foundation. Long-term results after proton irradiation of uveal melanomas.

E S Gragoudas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176673     DOI: 10.1007/BF01739634

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  8 in total

1.  Long-term observations of proton-irradiated monkey eyes.

Authors:  E S Gragoudas; N Z Zakov; D M Albert; I J Constable
Journal:  Arch Ophthalmol       Date:  1979-11

2.  Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.

Authors:  E S Gragoudas; M Goitein; L Verhey; J Munzenreider; M Urie; H Suit; A Koehler
Journal:  Arch Ophthalmol       Date:  1982-06

3.  Cobalt plaque therapy of posterior uveal melanomas.

Authors:  J A Shields; J J Augsburger; L W Brady; J L Day
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

4.  Proton irradiation of small choroidal malignant melanomas.

Authors:  E S Gragoudas; M Goitein; A M Koehler; L Verhey; J Tepper; H D Suit; R Brockhurst; I J Constable
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

5.  beta-Irradiation of choroidal melanoma with 106Ru/106Rh applicators. 16 Years' experience.

Authors:  P K Lommatzsch
Journal:  Arch Ophthalmol       Date:  1983-05

6.  Helium ion therapy for choroidal melanoma.

Authors:  D H Char; W Saunders; J R Castro; J M Quivey; A R Irvine; R D Stone; J B Crawford; M Barricks; L I Lonn; G F Hilton
Journal:  Ophthalmology       Date:  1983-10       Impact factor: 12.079

7.  Iodine-125 irradiation of choroidal melanoma. Clinical experience.

Authors:  S Packer; M Rotman; P Salanitro
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

8.  Relative survival rates after alternative therapies for uveal melanoma.

Authors:  J M Seddon; E S Gragoudas; K M Egan; R J Glynn; S Howard; R G Fante; D M Albert
Journal:  Ophthalmology       Date:  1990-06       Impact factor: 12.079

  8 in total
  5 in total

Review 1.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Where is the superiority of proton radiation for ocular tumours?

Authors:  Nikolaos E Bechrakis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-07       Impact factor: 3.117

3.  Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.

Authors:  Devron H Char; Riley Bove; Theodore L Phillips
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 4.  The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review.

Authors:  Geertruida E Bekkering; Anne W S Rutjes; Vasiliy V Vlassov; Daniel M Aebersold; Konrade von Bremen; Peter Jüni; Jos Kleijnen
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

5.  Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.

Authors:  Evangelos S Gragoudas; Anne Marie Lane; John Munzenrider; Kathleen M Egan; Wenjun Li
Journal:  Trans Am Ophthalmol Soc       Date:  2002
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.